Annual report pursuant to Section 13 and 15(d)

Intangible Assets and Impairment of Long-Lived Assets (Details) - Schedule of goodwill activity

v3.23.1
Intangible Assets and Impairment of Long-Lived Assets (Details) - Schedule of goodwill activity - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2022
CBR Pharma Goodwill [Member]          
Goodwill [Line Items]          
Balance at beginning $ 8,335,698 $ 21,350,696 $ 23,085,278 $ 23,749,631 $ 23,749,631
Currency translation 708,713 (1,750,386) (1,734,582) (664,353)  
Balance before impairment 9,044,411 19,600,310      
Impairment of goodwill (9,044,411) (11,264,612)      
Balance at ending 8,335,698 21,350,696 23,085,278
180 LP Goodwill [Member]          
Goodwill [Line Items]          
Balance at beginning 5,630,017 13,238,255 13,238,255 13,238,255 13,238,255
Currency translation  
Balance before impairment 5,630,017 13,238,255      
Impairment of goodwill (5,630,017) (7,608,238)      
Balance at ending 5,630,017 13,238,255 13,238,255
Consolidated Goodwill [Member]          
Goodwill [Line Items]          
Balance at beginning 13,965,715 34,588,951 36,323,533 36,987,886 36,987,886
Currency translation 708,713 (1,750,386) (1,734,582) (664,353)  
Balance before impairment 14,674,428 32,838,565      
Impairment of goodwill (14,674,428) (18,872,850)      
Balance at ending 13,965,715 34,588,951 36,323,533
CBR Pharma IP R&D Assets [Member]          
Goodwill [Line Items]          
Balance at beginning 1,347,516 1,467,854 1,587,106 1,632,780 1,632,780
Currency translation 114,568 (120,338) (119,252) (45,674)  
Balance before impairment 1,462,084        
Impairment of IP R&D assets (1,462,084)        
Balance at ending 1,347,516 1,467,854 1,587,106
180 LP IP R&D Assets          
Goodwill [Line Items]          
Balance at beginning 10,943,000 10,943,000 10,943,000 10,943,000 10,943,000
Currency translation  
Balance before impairment 10,943,000        
Impairment of IP R&D assets (1,880,000)        
Balance at ending 9,063,000 10,943,000 10,943,000 10,943,000 9,063,000
Consolidated IP R&D Assets [Member]          
Goodwill [Line Items]          
Balance at beginning 12,290,516 12,410,854 12,530,106 12,575,780 12,575,780
Currency translation 114,568 (120,338) (119,252) (45,674)  
Balance before impairment 12,405,084        
Impairment of IP R&D assets (3,342,084)        
Balance at ending $ 9,063,000 $ 12,290,516 $ 12,410,854 $ 12,530,106 $ 9,063,000